Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

UMN Pharma Inc

+ Add to Watchlist

4585:JP

2,986.0 JPY 13.0 0.44%

As of 00:00:51 ET on 03/31/2015.

Snapshot for UMN Pharma Inc (4585)

Open: 2,970.0 Day's Range: 2,970.0 - 3,015.0 Volume: 25,100
Previous Close: 2,973.0 52wk Range: 2,092.0 - 3,960.0 1-Yr Rtn: +40.32%

Stock Chart for 4585

No chart data available.
  • 4585:JP 2,985.0
  • 1D
  • 1M
  • 1Y
2,973.0
Interactive 4585 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4585

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -452.3400
Est. EPS (JPY) (12/2015) -55.4000
Est. PEG Ratio -
Market Cap (M JPY) 28,484.78
Shares Outstanding (M) 9.57
30 Day Average Volume 87,357
Price/Book (mrq) 7.7011
Price/Sale (ttm) 23.5892
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4585

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4585

UMN Pharma Inc. researches, develops, manufactures and distributes Bio-pharmaceutical products. The Company focuses on development of vaccines for influenza with specialized partners.

Tatsuyoshi HiranoChairman/PresidentFumihisa NakataDirector
Hiroyuki HashimotoDirector
More Company Profile & Key Executives for 4585

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil